Vimarsana
Biggest News Aggregation in the World

Rob Kettell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rob Kettell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rob Kettell Today - Breaking & Trending Today

'My breast cancer will kill me but one drug could extend my life' - Vimarsana News

'My breast cancer will kill me but one drug could extend my life'

Published: January 12, 2024

{"desktop":[{"injectionEnabled":false,"componentType":"gpt","targeting":{"index":-1,"hivis":"n"},"referenceNode":"header","hideOnSensitiveArticle":true,"hideOnFirstPageView":true,"relativePos":"after","name":"div-gpt-ad-oop-slot","isOOP":true,"type":"outOfPage"},{"componentType":"gpt","targeting":{"index":-2,"hivis":"n"},"referenceNode":&...

Source: bristolpost.co.uk
Related Topics:
United KingdomRichmond Upon ThamesCharing CrossNadia SawalhaDaiichi SankyoRob KettellHannah GardnerCancer Drugs FundNational Institute For HealthLilah RaeBreast Cancer NowCharing Cross HospitalRoyal Marsden HospitalLas VegasNational InstituteCare ExcellenceLoose WomenCancer Now
Voluntary levy on drug manufacturers will save NHS £7bn in five years, says government - Vimarsana News

Voluntary levy on drug manufacturers will save NHS £7bn in five years, says government

Published: April 27, 2023

The Pharmaceutical Journal from the Royal Pharmaceutical Society

Source: pharmaceutical-journal.com
Related Topics:
United KingdomJessamy BairdRob KettellEli LillyAssociation Of The British Pharmaceutical IndustryDepartment Of HealthLondon School Of EconomicsMembers Of The British Generic Manufacturers AssociationOffice Of Health EconomicsSocial CareBritish Pharmaceutical IndustrySanofi United KingdomPharmaceutical JournalBritish Generic Manufacturers AssociationLondon SchoolHealth EconomicsWill Quince
NHS set to save £7 billion thanks to world-leading medicine pricing scheme - Vimarsana News

NHS set to save £7 billion thanks to world-leading medicine pricing scheme

Published: April 24, 2023

Voluntary scheme for branded medicines pricing and access (VPAS) delivers value for money to taxpayer and saves NHS billions, facilitating patient access to new lifesaving treatments and medicines, and supporting UK life sciences sector.

Source: gov.uk
Related Topics:
United KingdomHugh TaylorRob KettellSir Hugh TaylorWorld Health OrganizationCancer Drugs FundDepartment Of HealthWill QuinceCancer DrugsNegotiations AdvisorSocial CareCommercial Medicines Negotiation